Skip to content

Glycogen and Appetite

The Effect of Suppression of Adipose Lipolysis on GLP-1 and Energy Intake in Men and Women

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05417659
Enrollment
15
Registered
2022-06-14
Start date
2022-10-10
Completion date
2024-08-30
Last updated
2025-03-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Energy Intake

Brief summary

Obesity is the outcome of chronic excessive energy intake and reduced energy expenditure leading to energy imbalance. It is a risk factor for many preventable diseases such as metabolic disease and its consequences such as type 2 diabetes and cardiovascular disease. Sedentary adults have been shown to have an increased appetite in excess of energy requirements and adults who are more active are able to better regulate energy intake. It is thought that carbohydrate availability and specifically hepatic glycogen utilisation during exercise is a regulator of appetite. However, the majority of research so far does not support this theory, potentially due to research not examining the tissue-specific link between glycogen use and appetite. The aim of this study is to assess whether altering substrate utilisation during exercise by suppressing lipolysis influences GLP-1 levels and caloric intake post exercise. Additionally, the study will explore if there is a tissue specific link between substrate utilisation and post exercise energy intake and examine potential sex differences.

Interventions

DIETARY_SUPPLEMENTExercise plus carbohydrate

A high carbohydrate drink to be consumed 1 hour prior to exercise and every 15 minutes during exercise.

DIETARY_SUPPLEMENTExercise plus niacin

A dose of niacin to be consumed 30 minutes prior to exercise, at onset of exercise and 30 minutes into exercise.

OTHERPlacebo

A placebo drink to be consumed 1 hour prior to exercise and every 15 minutes during exercise and placebo tablets to be consumed 30 minutes prior to exercise, at the onset of exercise and 30 minutes into exercise.

Sponsors

University of Bath
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* Males aged 18-60 and premenopausal women * Physically active (at least 30 minutes of exercise 3 times a week) * Body mass index 18.0-30.0 kg·m-2

Exclusion criteria

* Weight instability (\>5kg change in body mass over last 6 months) * Restrained eater (e.g. limiting food intake, calorie counting) * Current smoker * Aversion or allergy to test meal foods * Pregnant or lactating * Amenorrhoea in women * Any medical condition or medication that could introduce bias into the study (e.g., diabetes, CVD, lipid or glucose metabolism altering medications) * Any cardiopulmonary condition prohibiting exercise testing * Any contraindication to niacin or aspirin (e.g., diabetes, gout, clotting disorders, allergy to non-steroidal anti-inflammatory drugs)

Design outcomes

Primary

MeasureTime frameDescription
Difference in ad libitum energy intake2 hours post exerciseDifference between ad libitum energy intake (kcal) post exercise between trials

Other

MeasureTime frameDescription
Change in plasma leptin concentrations post exercise2 hoursIncremental area under the curve of plasma leptin concentrations
Change in plasma insulin concentrations during exercise1 hourIncremental area under the curve for plasma insulin concentrations
Change in plasma non-esterified fatty acid concentrations during exercise1 hourIncremental area under the curve for plasma non-esterified fatty acid concentrations
Change in plasma glucose concentrations during exercise1 hourIncremental area under the curve for plasma glucose concentrations
Change in plasma lactate concentrations during exercise1 hourIncremental area under the curve for plasma lactate concentrations
Change in carbohydrate oxidation during exercise1 hourIncremental area under the curve for carbohydrate oxidation
Change in plasma GLP-1 concentrations post exercise2 hoursIncremental area under the curve of plasma GLP-1 concentrations
Change in skin temperature during exercise1 hourIncremental area under the curve for skin temperature
Change in core body temperature during exercise1 hourIncremental area under the curve for core body temperature
Muscle glycogen utilisation1 hourDifference in muscle glycogen utilisation during exercise between conditions
Extra-muscular glycogen oxidation1 hourDifference in extra muscular glycogen oxidation during exercise between conditions
Difference in blood pressure between conditions3 hoursDifference in blood pressure between conditions
Change in fat oxidation during exercise1 hourIncremental area under the curve for fat oxidation

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 9, 2026